From: A three-country comparison of psychotropic medication prevalence in youth
 | US (n = 127,157) | Netherlands (n = 110,944) | Germany (n = 356,520) | ||||||
---|---|---|---|---|---|---|---|---|---|
Age (yr) | Male | Female | Total* | Male | Female | Total* | Male | Female | Total* |
0–4 | 0.11 | 0.02 | 0.07 | 0.14 | 0.05 | 0.10 | 0.74 | 0.53 | 0.64 |
 | 0.08–0.15 | 0.09–0.45 | 0.06–0.07 | 0.09–0.22 | 0.02–0.11 | 0.09–0.10 | 0.65–0.83 | 0.45–0.60 | 0.63–0.64 |
5–9 | 1.04 | 0.20 | 0.63 | 0.76 | 0.16 | 0.47 | 0.29 | 0.16 | 0.23 |
 | 0.87–1.23 | 0.13–0.30 | 0.62–0.64 | 0.62–0.92 | 0.10–0.24 | 0.46–0.47 | 0.24–0.34 | 0.12–0.20 | 0.22–0.23 |
10–14 | 1.57 | 0.56 | 1.08 | 1.26 | 0.29 | 0.79 | 0.27 | 0.14 | 0.21 |
 | 1.33–1.83 | 0.42–0.73 | 1.07–1.09 | 1.08–1.47 | 0.21–0.4 | 0.78–0.79 | 0.22–0.31 | 0.11–0.18 | 0.20–0.21 |
15–19 | 1.60 | 0.80 | 1.21 | 0.85 | 0.45 | 0.66 | 0.30 | 0.32 | 0.31 |
 | 1.32–1.92 | 0.63–1.00 | 1.20–1.22 | 0.71–1.00 | 0.35–0.57 | 0.65–0.66 | 0.26–0.36 | 0.27–0.38 | 0.31–0.31 |
Total* | 1.10 | 0.40 | 0.76 | 0.76 | 0.24 | 0.51 | 0.39 | 0.28 | 0.34 |
 | 1.09–1.10 | 0.40–0.40 | 0.75–0.76 | 0.76–0.77 | 0.24–0.24 | 0.51–0.51 | 0.39–0.40 | 0.28–0.28 | 0.34–0.34 |